The heart function of DCM rats with chronic heart failure was significantly improved by NRG-1, supporting the rationale of replenishing NRG-1 as an optional selection for DCM therapy, although further clinical studies are required. The gene discussed is NRG1; the disease is familial dilated cardiomyopathy.